National Council for Prescription Drug Programs indexing - billing unit
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2013-02-13
- Label type
- Indexing - Billing Unit
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 03:41:53
Label at a glance#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 11704-106-01 | ML - Milliliter | 11704-106 | 47d8a3d1-ec6b-4306-a7c6-562b5de45a58 | 1 | 2013-02-13 |
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 11704-106 | 11704-106-01 |
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N017106-001 | ATROPEN | ATROPINE | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD, Approved before 1982 | ||
| N017106-002 | ATROPEN | ATROPINE | EQ 1MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | |
| N017106-003 | ATROPEN | ATROPINE | EQ 0.5MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | |
| N017106-004 | ATROPEN | ATROPINE | EQ 0.25MG SULFATE/0.3ML | SOLUTION / INTRAMUSCULAR | RLD | 2004-09-17 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N017106-001 | ATROPEN | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD, Approved before 1982 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N017106-002 | ATROPEN | EQ 1MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N017106-003 | ATROPEN | EQ 0.5MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N017106-004 | ATROPEN | EQ 0.25MG SULFATE/0.3ML | SOLUTION / INTRAMUSCULAR | RLD | 2004-09-17 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N017106-001 | ATROPEN | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD, Approved before 1982 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N017106-002 | ATROPEN | EQ 1MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N017106-003 | ATROPEN | EQ 0.5MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N017106-004 | ATROPEN | EQ 0.25MG SULFATE/0.3ML | SOLUTION / INTRAMUSCULAR | RLD | 2004-09-17 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N017106-001 | ATROPEN | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD, Approved before 1982 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N017106-002 | ATROPEN | EQ 1MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N017106-003 | ATROPEN | EQ 0.5MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N017106-004 | ATROPEN | EQ 0.25MG SULFATE/0.3ML | SOLUTION / INTRAMUSCULAR | RLD | 2004-09-17 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N017106-001 | ATROPEN | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD, Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N017106-002 | ATROPEN | EQ 1MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N017106-003 | ATROPEN | EQ 0.5MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N017106-004 | ATROPEN | EQ 0.25MG SULFATE/0.3ML | SOLUTION / INTRAMUSCULAR | RLD | 2004-09-17 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N017106-001 | ATROPEN | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD, Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N017106-002 | ATROPEN | EQ 1MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N017106-003 | ATROPEN | EQ 0.5MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N017106-004 | ATROPEN | EQ 0.25MG SULFATE/0.3ML | SOLUTION / INTRAMUSCULAR | RLD | 2004-09-17 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N017106-001 | ATROPEN | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N017106-002 | ATROPEN | EQ 1MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N017106-003 | ATROPEN | EQ 0.5MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N017106-004 | ATROPEN | EQ 0.25MG SULFATE/0.3ML | SOLUTION / INTRAMUSCULAR | RLD | 2004-09-17 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N017106-001 | ATROPEN | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N017106-002 | ATROPEN | EQ 1MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N017106-003 | ATROPEN | EQ 0.5MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N017106-004 | ATROPEN | EQ 0.25MG SULFATE/0.3ML | SOLUTION / INTRAMUSCULAR | RLD | 2004-09-17 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N017106-001 | ATROPEN | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD, Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N017106-002 | ATROPEN | EQ 1MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N017106-003 | ATROPEN | EQ 0.5MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N017106-004 | ATROPEN | EQ 0.25MG SULFATE/0.3ML | SOLUTION / INTRAMUSCULAR | RLD | 2004-09-17 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N017106-001 | ATROPEN | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD, Approved before 1982 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N017106-002 | ATROPEN | EQ 1MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N017106-003 | ATROPEN | EQ 0.5MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N017106-004 | ATROPEN | EQ 0.25MG SULFATE/0.3ML | SOLUTION / INTRAMUSCULAR | RLD | 2004-09-17 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N017106-001 | ATROPEN | EQ 2MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD, Approved before 1982 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N017106-002 | ATROPEN | EQ 1MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N017106-003 | ATROPEN | EQ 0.5MG SULFATE/0.7ML | SOLUTION / INTRAMUSCULAR | RLD | 2003-06-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N017106-004 | ATROPEN | EQ 0.25MG SULFATE/0.3ML | SOLUTION / INTRAMUSCULAR | RLD | 2004-09-17 | 2680178bc6a6… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ATROPEN Auto-Injector | ATROPINE | Meridian Medical Technologies LLC | e2d4307d-da8f-49f5-aac0-02355dd9ffb7 | 2022-09-15 | Warnings, Adverse reactions | 11704-106-01 11704010601 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.